For nearly five years, researchers have been wielding the molecular scissors known as CRISPR/Cas9 to make precise changes in animals’ DNA. But its use in human embryos has more profound ...
The lab's ultimate reason for focusing on vectors that work in vivo is to make CRISPR therapies more broadly available and cheaper. In a recent essay in Wired magazine, Doudna referred to the ...